Streetbeat News

GTLB

GitLab Inc.

https://about.gitlab.com

Industry

Software - Application

GitLab Inc., through its subsidiaries, develops software for the software development lifecycle in the United States, Europe, and the Asia Pacific. The company offers GitLab, a DevOps platform, which is a single application that leads to faster cycle time and allows visibility throughout and control over various stages of the DevOps lifecycle. It helps organizations to plan, build, secure, and deploy software to drive business outcomes. The company also provides related training and professional services. The company was formerly known as GitLab B.V. and changed its name to GitLab Inc. in July 2015. The company was founded in 2011 and is headquartered in San Francisco, California.

Open

N/A

Mkt cap

N/A

Volume

N/A

High

N/A

P/E Ratio

N/A

52-wk high

N/A

Low

N/A

Div yield

N/A

52-wk low

N/A

GitLab Inc. has launched the GitLab Duo Enterprise add-on, priced at $39 per user per month, offering AI capabilities for DevSecOps teams. This follows GitLab's recognition as a Leader in the 2024 Gartner Magic Quadrant for AI Code Assistants.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 8:20 pm

The article highlights significant options activity in the Information Technology sector, focusing on trades involving companies like NVDA, AAPL, MSFT, AMD, SMCI, PANW, PLTR, BTDR, GTLB, and MARA. These activities include both call and put options with varying sentiments, indicating potential market movements.

Portfolio Pulse from Benzinga Insights

August 19, 2024 | 5:35 pm

Cantor Fitzgerald analyst Yi Fu Lee has reiterated an Overweight rating on GitLab (NASDAQ:GTLB) and maintained a $55 price target.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 3:57 pm

Shares of stocks in the broader tech sector are trading lower as stocks sell off amid concerns over the US economy.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 2:11 pm

Eleven mid-cap stocks performed exceptionally well last week (July 14-July 20). Key performers include Virtu Financial, V.F. Corporation, New Fortress Energy, Riot Platforms, Clarivate, AMN Healthcare Services, BankUnited, Marathon Digital Holdings, eXp World Holdings, Zeta Global Holdings, and NCR Atleos Corporation.

Portfolio Pulse from Lekha Gupta

July 21, 2024 | 4:07 pm

Cathie Wood's Ark Invest sold $8 million worth of Tesla shares despite a bullish forecast on Tesla's potential in the autonomous taxi sector. The ARK Next Generation Internet ETF sold 32,199 shares of Tesla. Additionally, Ark Invest's Genomic Revolution ETF bought shares of Guardant Health, 10X Genomics, and Beam Therapeutics, while the ARKW fund also bought shares of GitLab.

Portfolio Pulse from Benzinga Neuro

July 19, 2024 | 2:12 am

Analysts have mixed views on GitLab (NASDAQ:GTLB) with recent ratings showing a decrease in average price targets by 10.85%. The 12-month price targets range from $50.00 to $80.00. GitLab's financial health shows strong revenue growth but challenges in profitability and returns.

Portfolio Pulse from Benzinga Insights

July 18, 2024 | 5:00 pm

RBC Capital analyst Matthew Hedberg has reiterated an Outperform rating on GitLab (NASDAQ:GTLB) and maintained a $65 price target.

Portfolio Pulse from Benzinga Newsdesk

July 18, 2024 | 2:42 pm

Datadog Inc. (NASDAQ:DDOG) shares are trading lower following reports of a potential acquisition of GitLab Inc. (NASDAQ:GTLB), valued at approximately $8 billion. Both companies and Alphabet, a significant GitLab stakeholder, have declined to comment. Analyst Mike Cikos suggests the acquisition could be beneficial despite AWS or Google Cloud being seen as more obvious buyers.

Portfolio Pulse from Vaishali Prayag

July 17, 2024 | 8:05 pm

ASLAN Pharmaceuticals shares dropped over 38% after announcing the voluntary liquidation of its sole operating subsidiary. Other notable stock movements include Aptevo Therapeutics climbing 84% following a $2.75 million offering, and Shimmick Corporation rising 49% after securing a $27.6 million subcontract. Cassava Sciences fell nearly 30% due to executive leadership changes.

Portfolio Pulse from Avi Kapoor

July 17, 2024 | 5:28 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.